{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:39:53Z","timestamp":1776872393325,"version":"3.51.2"},"reference-count":18,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Febrile neutropenia (FN) is a serious complication of chemotherapy that often leads to hospitalization in cancer patients. It is now well-established that carefully selected patients can be safely treated on an outpatient basis. The objective of this study was to assess the number and proportion of patients hospitalized for FN in a university hospital setting who would have met the low-risk criteria for FN, and whether these patients experienced favorable outcomes during hospitalization. We conducted a retrospective study of all patients admitted for FN at three hospitals in Quebec City between 1 January 2018 and 31 December 2019. Patients with leukemia and those who had undergone stem cell transplants were excluded. A retrospective chart review was performed to establish the Multinational Association for Supportive Care in Cancer (MASCC) score for each patient. Based on predefined criteria, we also determined whether the clinical course was favorable or unfavorable. A total of 177 hospitalizations met our inclusion criteria. We found that 101\/177 (57.1%) of the hospitalized patients met the low-risk FN criteria according to their MASCC score. Among these, 74\/177 (41.8%) met all the criteria for outpatient treatment. The majority of these patients had a favorable outcome (70\/74, 94.6%). In contrast, among patients who did not meet the eligibility criteria for outpatient treatment, 44.7% (46\/103) experienced favorable outcomes during their hospitalization. These data highlight the importance of patient selection for outpatient care.<\/jats:p>","DOI":"10.3390\/curroncol32030133","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T11:22:12Z","timestamp":1740568932000},"page":"133","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Real-World Data to Assess the Proportion of Patients Admitted for Febrile Neutropenia That Could Be Considered at Low Risk: The Experience of the Centre Hospitalier Universitaire de Qu\u00e9bec"],"prefix":"10.3390","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9254-7189","authenticated-orcid":false,"given":"Tommy","family":"Jean","sequence":"first","affiliation":[{"name":"CHU de Qu\u00e9bec, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Laval, Quebec, QC G1J 0J9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Sylvestre","sequence":"additional","affiliation":[{"name":"CHU de Qu\u00e9bec, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Laval, Quebec, QC G1J 0J9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Caron","sequence":"additional","affiliation":[{"name":"CHU de Qu\u00e9bec, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Laval, Quebec, QC G1J 0J9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Leblanc","sequence":"additional","affiliation":[{"name":"CHU de Qu\u00e9bec, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Laval, Quebec, QC G1J 0J9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Soucy","sequence":"additional","affiliation":[{"name":"CHU de Qu\u00e9bec, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Laval, Quebec, QC G1J 0J9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Lemieux","sequence":"additional","affiliation":[{"name":"CHU de Qu\u00e9bec, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Laval, Quebec, QC G1J 0J9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.21847","article-title":"Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients","volume":"106","author":"Kuderer","year":"2006","journal-title":"Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Perron, T., Emara, M., and Ahmed, S. (2014). Time to antibiotics and outcomes in cancer patients with febrile neutropenia. BMC Health Serv. Res., 14.","DOI":"10.1186\/1472-6963-14-162"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1200\/JCO.2005.03.9909","article-title":"Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications","volume":"24","author":"Klastersky","year":"2006","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1200\/JCO.2012.45.8109","article-title":"Oral antibiotics for fever in low-risk neutropenic patients with cancer: A double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin\/clavulanic acid combination therapy\u2014EORTC infectious diseases group trial XV","volume":"31","author":"Kern","year":"2013","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/bjc.2011.101","article-title":"Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients","volume":"104","author":"Teuffel","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e552","DOI":"10.1200\/JOP.2016.019588","article-title":"Cost of Cancer-Related Neutropenia or Fever Hospitalizations, United States, 2012","volume":"13","author":"Tai","year":"2017","journal-title":"J. Oncol. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hwang, S., Kwon, K.T., Kim, Y., Bae, S., Chang, H.H., Kim, S.W., Yoo, S.S., Nam, S.Y., and Baek, J.H. (2021). Usefulness analysis of the 2018 ASCO\/IDSA guideline for outpatient management of fever and neutropenia in adults treated for malignancy. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-88207-6"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","article-title":"Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1200\/JCO.2012.45.8661","article-title":"Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline","volume":"31","author":"Flowers","year":"2013","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1001\/archinte.1988.00380120031007","article-title":"The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation","volume":"148","author":"Talcott","year":"1988","journal-title":"Arch. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","article-title":"Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology","volume":"14","author":"Baden","year":"2016","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1200\/JCO.2014.57.2347","article-title":"Prediction of serious complications in patients with seemingly stable febrile neutropenia: Validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study","volume":"33","author":"Antonio","year":"2015","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","article-title":"The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients","volume":"18","author":"Klastersky","year":"2000","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jemermed.2019.09.032","article-title":"Emergency Ambulatory Management of Low-Risk Febrile Neutropenia: Multinational Association for Supportive Care in Cancer Fits-Real-World Experience from a UK Cancer Center","volume":"58","author":"Marshall","year":"2020","journal-title":"J. Emerg. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12288-016-0730-7","article-title":"Validation of MASCC Score for Risk Stratification in Patients of Hematological Disorders with Febrile Neutropenia","volume":"33","author":"Taj","year":"2017","journal-title":"Indian J. Hematol. Blood Transfus. Off. J. Indian Soc. Hematol. Blood Transfus."},{"key":"ref_16","first-page":"5905","article-title":"Use of MASCC score in the inpatient management of febrile neutropenia: A single-center retrospective study","volume":"29","author":"Bhardwaj","year":"2021","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/bjc.2011.284","article-title":"Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients","volume":"105","author":"Canteras","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00520-023-08065-y","article-title":"Ambulatory management of low-risk febrile neutropenia in adult oncological patients","volume":"31","year":"2023","journal-title":"Systematic review. Supportive care in cancer: Official journal of the Multinational Association of Supportive Care in Cancer"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/3\/133\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:43:20Z","timestamp":1760028200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/3\/133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["curroncol32030133"],"URL":"https:\/\/doi.org\/10.3390\/curroncol32030133","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]}}}